Daily Versus As-needed Inhaled Corticosteroid for Mild Persistent Asthma (The Helsinki Early Intervention Childhood Asthma Study)

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 2007 Jul 20

PMID 17634183

Citations 24

Authors

M Turpeinen

K Nikander

A S Pelkonen

P Syvanen

R Sorva

H Raitio

P Malmberg

K Juntunen-Backman

T Haahtela

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the effect of inhaled budesonide given daily or as-needed on mild persistent childhood asthma. Patients, design and

Interventions: 176 children aged 5-10 years with newly detected asthma were randomly assigned to three treatment groups: (1) continuous budesonide (400 microg twice daily for 1 month, 200 microg twice daily for months 2-6, 100 microg twice daily for months 7-18); (2) budesonide, identical treatment to group 1 during months 1-6, then budesonide for exacerbations as needed for months 7-18; and (3) disodium cromoglycate (DSCG) 10 mg three times daily for months 1-18. Exacerbations were treated with budesonide 400 microg twice daily for 2 weeks.

Main Outcome Measures: Lung function, the number of exacerbations and growth.

Results: Compared with DSCG the initial regular budesonide treatment resulted in a significantly improved lung function, fewer exacerbations and a small but significant decline in growth velocity. After 18 months, however, the lung function improvements did not differ between the groups. During months 7-18, patients receiving continuous budesonide treatment had significantly fewer exacerbations (mean 0.97), compared with 1.69 in group 2 and 1.58 in group 3. The number of asthma-free days did not differ between regular and intermittent budesonide treatment. Growth velocity was normalised during continuous low-dose budesonide and budesonide therapy given as needed. The latter was associated with catch-up growth.

Conclusions: Regular use of budesonide afforded better asthma control but had a more systemic effect than did use of budesonide as needed. The dose of ICS could be reduced as soon as asthma is controlled. Some children do not seem to need continuous ICS treatment.

Citing Articles

Budesonide Attains Its Wide Clinical Profile by Alternative Kinetics.

Brattsand R, Selroos O Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675463 PMC: 11055149. DOI: 10.3390/ph17040503.

Anthropometric Parameters in Asthmatic Children and the Relationship of Childhood Asthma with Height, Weight and Body Mass Index.

Bazargan N, Hamidifar S, Khalouei A, Sedighi G J Pharm Res Int. 2023; 27(5).

PMID: 37206539 PMC: 10194024. DOI: 10.9734/jpri/2019/v27i530181.

2022 Year in Review: Pediatric Asthma.

Baker J Respir Care. 2023; 68(10):1430-1437.

PMID: 37160339 PMC: 10506641. DOI: 10.4187/respcare.10913.

Comparison of National and Global Asthma Management Guiding Documents.

Baker J, Houin P Respir Care. 2022; 68(1):114-128.

PMID: 36566032 PMC: 9993509. DOI: 10.4187/respcare.10254.

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.

Cloutier M, Baptist A, Blake K, Brooks E, Bryant-Stephens T, DiMango E J Allergy Clin Immunol. 2020; 146(6):1217-1270.

PMID: 33280709 PMC: 7924476. DOI: 10.1016/j.jaci.2020.10.003.

References

Visser M, Postma D, Arends L, De Vries T, Duiverman E, Brand P . One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med. 2001; 164(11):2073-7. DOI: 10.1164/ajrccm.164.11.2103075. View

Waalkens H, van Essen-Zandvliet E, Hughes M, Gerritsen J, Duiverman E, KNOL K . Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis. 1993; 148(5):1252-7. DOI: 10.1164/ajrccm/148.5.1252. View

Pauwels R, Pedersen S, Busse W, Tan W, Chen Y, Ohlsson S . Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003; 361(9363):1071-6. DOI: 10.1016/S0140-6736(03)12891-7. View

Powell H, Gibson P . High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database Syst Rev. 2004; (2):CD004109. PMC: 6482394. DOI: 10.1002/14651858.CD004109.pub2. View

Sorva R, Perheentupa J, Tolppanen E . A novel format for a growth chart. Acta Paediatr Scand. 1984; 73(4):527-9. DOI: 10.1111/j.1651-2227.1984.tb09965.x. View

Aberg N, Engstrom I . Natural history of allergic diseases in children. Acta Paediatr Scand. 1990; 79(2):206-11. DOI: 10.1111/j.1651-2227.1990.tb11440.x. View

van Essen-Zandvliet E, Hughes M, Waalkens H, Duiverman E, Pocock S, Kerrebijn K . Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992; 146(3):547-54. DOI: 10.1164/ajrccm/146.3.547. View

Todd G, Acerini C, Ross-Russell R, Zahra S, Warner J, McCance D . Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002; 87(6):457-61. PMC: 1755820. DOI: 10.1136/adc.87.6.457. View

Szefler S, Weiss S, Tonascia J, Adkinson N, Bender B, Cherniack R . Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000; 343(15):1054-63. DOI: 10.1056/NEJM200010123431501. View

10.

Agertoft L, Pedersen S . Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994; 88(5):373-81. DOI: 10.1016/0954-6111(94)90044-2. View

11.

Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K . Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994; 331(11):700-5. DOI: 10.1056/NEJM199409153311103. View

12.

Doull I, Freezer N, Holgate S . Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med. 1995; 151(6):1715-9. DOI: 10.1164/ajrccm.151.6.7767512. View

13.

. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152(3):1107-36. DOI: 10.1164/ajrccm.152.3.7663792. View

14.

Selroos O, Pietinalho A, Lofroos A, Riska H . Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995; 108(5):1228-34. DOI: 10.1378/chest.108.5.1228. View

15.

Pelkonen A, Hakulinen A, Turpeinen M . Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med. 1997; 156(4 Pt 1):1178-84. DOI: 10.1164/ajrccm.156.4.9610028. View

16.

Simons F . A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997; 337(23):1659-65. DOI: 10.1056/NEJM199712043372304. View

17.

. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J. 1998; 10(11):2662-89. DOI: 10.1183/09031936.97.10112662. View

18.

Barnes P . Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol. 1998; 102(4 Pt 1):531-8. DOI: 10.1016/s0091-6749(98)70268-4. View

19.

Zeiger R, Dawson C, Weiss S . Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol. 1999; 103(3 Pt 1):376-87. DOI: 10.1016/s0091-6749(99)70460-4. View

20.

Boushey H, Sorkness C, King T, Sullivan S, Fahy J, Lazarus S . Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005; 352(15):1519-28. DOI: 10.1056/NEJMoa042552. View